Inventor · disambiguated record
Patricio Manuel Vieira Araujo Soares Da Silva
Also filed as: SOARES DA SILVA PATRICIO · SOARES DA SILVA PATRICIO MANUEL · SOARES DA SILVA PATRICIO MANUEL V A · SOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO
30 granted patents·31 pending applications·82 citations·filing 2001–2024
96Inventor score
Files withBIAL PORTELA & CA SA30BIAL - PORTELA & CA S A13SOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO4BIAL PORTELA & Cª S A3LEARMONTH DAVID ALEXANDER2
Top patents by PatentIndex Score
61 records- 0192US8907099B2Nitrocatechol derivatives as COMT inhibitorsLEARMONTH DAVID ALEXANDER·Filed 2012·Granted Dec 9, 2014·16 cites·8 claims
- 0285US10357468B2Medicaments for slowing Parkinson's diseaseBIAL—PORTELA & CA S A·Filed 2015·Granted Jul 23, 2019·8 cites·21 claims
- 0385US9550759B2Nitrocatechol derivatives as COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2014·Granted Jan 24, 2017·5 cites·8 claims
- 0485US9446012B2Pharmaceutical compoundsBIAL-PORTELA & CA S A·Filed 2013·Granted Sep 20, 2016·7 cites·14 claims
- 0582US10023541B2Urea compounds and their use as enzyme inhibitorsBIAL PORTELA & CA SA·Filed 2016·Granted Jul 17, 2018·4 cites·8 claims
- 0682US9763954B2Therapeutical uses of eslicarbazepineBIAL-PORTELA & CA S A·Filed 2013·Granted Sep 19, 2017·4 cites·28 claims
- 0782US9549915B2Urea compounds and their use as enzyme inhibitorsBIAL-PORTELA & CA S A·Filed 2013·Granted Jan 24, 2017·6 cites·5 claims
- 0882US7259271B2Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparationPORTELA & CA SA·Filed 2006·Granted Aug 21, 2007·3 cites·12 claims
- 0981US9745290B2Dosage regimen for COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2015·Granted Aug 29, 2017·3 cites·15 claims
- 1081US2025275934A1Medicaments for slowing parkinson's diseaseBIAL PORTELA & CA SA·Filed 2024·Application pending·0 cites
- 1181US2025276963A1Administration regime for nitrocatecholsBIAL PORTELA & CA SA·Filed 2024·Application pending·0 cites
- 1280US10065944B2Administration regime for nitrocatecholsBIAL—PORTELA & CA S A·Filed 2013·Granted Sep 4, 2018·5 cites·6 claims
- 1380US8481582B21,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseSOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO·Filed 2008·Granted Jul 9, 2013·3 cites·9 claims
- 1478US9750747B2Treatments involving eslicarbazepine acetate or eslicarbazepineSOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO·Filed 2012·Granted Sep 5, 2017·4 cites·19 claims
- 1577US10675287B2Methods of treatment of partial onset seizures using eslicarbazepine acetateBIAL PORTELA & CA SA·Filed 2019·Granted Jun 9, 2020·0 cites·23 claims
- 1677US7125904B2Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparationPORTELA & CA SA·Filed 2003·Granted Oct 24, 2006·9 cites·19 claims
- 1777US2022388999A1Nitrocatechol derivatives as comt inhibitorsBIAL PORTELA & CA SA·Filed 2022·Application pending·0 cites
- 1876US10336740B2Nitrocatechol derivatives as COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2017·Granted Jul 2, 2019·1 cites·16 claims
- 1975US2023355560A1Medicaments for slowing parkinson's diseaseBIAL PORTELA & CA SA·Filed 2023·Application pending·0 cites
- 2074US2021261533A11,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL PORTELA & CA SA·Filed 2021·Application pending·0 cites
- 2174US2024000762A1Treatment regimens for early idiopathic parkinson's diseaseBIAL PORTELA & CA SA·Filed 2023·Application pending·0 cites
- 2273US11364247B2Methods of treatment of partial onset seizures using eslicarbazepine acetateBIAL PORTELA & CA SA·Filed 2020·Granted Jun 21, 2022·0 cites·22 claims
- 2373US9630951B21,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL-PORTELA & CA S A·Filed 2013·Granted Apr 25, 2017·1 cites·14 claims
- 2473US2023390267A1Treatment regimens for early idiopathic parkinson's diseaseBIAL PORTELA & CA SA·Filed 2023·Application pending·0 cites
- 2570US10695354B2Methods of treatment of partial onset seizures using eslicarbazepine acetateBIAL PORTELA & CA SA·Filed 2019·Granted Jun 30, 2020·0 cites·27 claims
- 2670US2020102295A1Nitrocatechol derivatives as comt inhibitorsBIAL PORTELA & CA SA·Filed 2019·Application pending·0 cites
- 2768US12129247B2Administration regime for nitrocatecholsBIAL PORTELA & CA SA·Filed 2018·Granted Oct 29, 2024·0 cites·17 claims
- 2868US10702536B2Methods of treatment of partial onset seizures using eslicarbazepine acetateBIAL PORTELA & CA SA·Filed 2017·Granted Jul 7, 2020·0 cites·30 claims
- 2966US9604970B21,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injuryBIAL—PORTELA & CA S A·Filed 2013·Granted Mar 28, 2017·1 cites·19 claims
- 3066US2022017523A1BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-ß-HYDROXYLASE INHIBITORSBIAL PORTELA & CA SA·Filed 2021·Application pending·0 cites
- 3165US9353082B2Pharmaceutical compoundsKISS LASZLO ERNO·Filed 2009·Granted May 31, 2016·2 cites·64 claims
- 3265US2021186910A1Medicaments for slowing parkinson's diseaseBIAL PORTELA & CA SA·Filed 2020·Application pending·0 cites
- 3364US2019322648A11,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL PORTELA & CA SA·Filed 2019·Application pending·0 cites
- 3464US2023138795A1Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & CA SA·Filed 2022·Application pending·0 cites
- 3563US11046654B2Urea compounds and their use as enzyme inhibitorsBIAL PORTELA & CA SA·Filed 2018·Granted Jun 29, 2021·0 cites·14 claims
- 3663US2014288058A1Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of useBIAL PORTELA & CA SA·Filed 2014·Application pending·0 cites
- 3761US2010048538A1Therapeutical Uses of EslicarbazepineBIAL PORTELA & CA SA·Filed 2008·Application pending·0 cites
- 3860US11034695B2Dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & CA S A·Filed 2017·Granted Jun 15, 2021·0 cites·25 claims
- 3959US10975083B2Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & Cᵃ S A·Filed 2017·Granted Apr 13, 2021·0 cites·21 claims
- 4059US9855277B2Use of 5H-dibenz/b,f/azepine-5-carboxamide derivatives for treating fibromyalgiaSOARES DA SILVA PATRICIO MANUEL VIERA ARAÚJO·Filed 2009·Granted Jan 2, 2018·0 cites·14 claims
- 4159US2020078328A1Medicaments for slowing parkinson's diseaseBIAL PORTELA & CA SA·Filed 2019·Application pending·0 cites
- 4258US2017369478A11,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL - PORTELA & CA S A·Filed 2017·Application pending·0 cites
- 4357US2024066015A1Treatment of pain associated with parkinson's diseaseBIAL PORTELA & CA SA·Filed 2021·Application pending·0 cites
- 4456US8158666B2Process for the preparation of (R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-YL)-1,3-dihydroimidazole-2-thioneSOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO·Filed 2008·Granted Apr 17, 2012·0 cites·16 claims
- 4555US2011319388A1Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of useDE ALMEIDA JOSE LUIS·Filed 2011·Application pending·0 cites
- 4654US11434242B2Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & Cª S A·Filed 2018·Granted Sep 6, 2022·0 cites·14 claims
- 4754US2018228812A1Therapeutical uses of eslicarbazepineBIAL PORTELA & CA SA·Filed 2017·Application pending·0 cites
- 4852US2016051560A1Treatments involving eslicarbazepine or eslicarbazepine acetateBIAL PORTELA & Cª S A·Filed 2014·Application pending·0 cites
- 4952US2019241545A11,3-Dihydroimidazole-2-Thione Derivatives for Use in the Treatment of Pulmonary Arterial Hypertension and Lung InjuryBIAL PORTELA & CA SA·Filed 2019·Application pending·0 cites
- 5051US10308640B21,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injuryBIAL—PORTELA & CA S A·Filed 2017·Granted Jun 4, 2019·0 cites·20 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →